Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome
Neurological Sciences · 2025-01 · 46 (1) · 479-481
DOI: 10.1007/s10072-024-07812-1 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neurological Sciences, online erschienen am 17.10.2024. Verfasst von Alix Buhlmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Intensive Care Medicine, University Hospital Zurich, Rämistrasse 100, Zurich, 8091, Switzerland. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich.
Abstract (Originalsprache)
With the rising number of patients receiving chimeric antigen receptor T-cells, the treatment of this therapy’s complications is of growing concern to intensivists and neurologists. We used extracorporeal cytokine adsorption as an add-on therapy in a patient suffering from immune effector cell-associated neurotoxicity syndrome. Interleukin-6 level, which as a readily available parameter is generally used to evaluate course of disease, was rapidly reduced using this method. The patient made a full recovery and is still in hematological remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Intensive Care Medicine, University Hospital Zurich, Rämistrasse 100, Zurich, 8091, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
- Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland.
- Institute of Intensive Care Medicine, University Hospital Zurich, Rämistrasse 100, Zurich, 8091, Switzerland. sascha.david@usz.ch.
Förderung
- University of Zurich
Zitieren
APA
Buhlmann, A., Rom, E., Schweiger, G., Schneidawind, D., & David, S. (2025). Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome. Neurological Sciences, 46(1), 479-481. https://doi.org/10.1007/s10072-024-07812-1
Vancouver
Buhlmann A, Rom E, Schweiger G, Schneidawind D, David S. Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome. Neurological Sciences. 2025;46(1):479-481. doi:10.1007/s10072-024-07812-1
BibTeX
@article{Buhlmann2025,
author = {Buhlmann, Alix and Rom, Emanuel and Schweiger, Giovanna and Schneidawind, Dominik and David, Sascha},
title = {Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome},
journal = {Neurological Sciences},
year = {2025},
volume = {46},
number = {1},
pages = {479--481},
doi = {10.1007/s10072-024-07812-1}
}
EUVIMED